| Patent Number |
Title Of Patent |
Date Issued |
| 7144886 |
Dipeptidyl peptidase IV (DP-IV) inhibitors as anti-diabetic agents |
December 5, 2006 |
| The present invention relates to a series of prodrugs of inhibitors of DP-IV with improved properties. The compounds can be used for the treatment of a number of human diseases, including impaired glucose tolerance and type II diabetes. The compounds of the invention are described by |
| 6818219 |
Reagent for detecting and monitoring viral infections |
November 16, 2004 |
| The invention concerns a reagent for diagnosing an infection caused by a virus, characterized in that it comprises essentially a mixture consisting of (1) an immunodominant fragment of a protein of said virus comprising not more than 60 aminoacids, preferably between 20 and 30 aminoacids |
| 6015564 |
Cytotoxic T lymphocyte-inducing lipopeptides and use as vaccines |
January 18, 2000 |
| Cytotoxic lymphocyte-inducing lipopeptides comprising a peptide part having between 10 and 40 amino acids approximately and comprising at least one tigenic determinant. The lipopeptides also comprise one or more chains derived from fatty acids and one or more modified steroid groups. Sa |
| 5993823 |
Cytotoxic T lymphocyte-inducing lipopeptides and methods of use |
November 30, 1999 |
| Cytotoxic lymphocyte-inducing lipopeptides comprising a peptide fragment having approximately between 10 and 40 amino acids and comprising at least one antigenic determinant and also comprising one or more chains derived from fatty acids and one or more modified steroid groups useful for |
| 5871746 |
Cytotoxic T lymphocyte-inducing lipopeptides and use as vaccines |
February 16, 1999 |
| Cytotoxic lymphocyte-inducing lipopeptides comprising a peptide part having between 10 and 40 amino acids approximately and comprising at least one antigenic determinant. The lipopeptides also comprise one or more chains derived from fatty acids and one or more modified steroid groups.Sa |
| 5824788 |
Cloning of gene encoding the GP28.5 protein of toxoplasma gondii; peptide fragments of said prot |
October 20, 1998 |
| The invention relates to cloning of the gene for the toxoplasma GP28.5 anen. It also encompasses purified GP28.5 antigen preparations and antigenic polypeptides derived from said antigen, and their applications. |
| 5541078 |
Antigenic peptide sequence of echinococcus granulosus and diagnostic applications |
July 30, 1996 |
| The immunogenic peptide sequence from Echinococcus granulosus antigen 5 is recognized both by sera from patients suffering from hydatidosis and by a monoclonal antibody of isotype IgG1 produced by hybridoma EG 02154/12 and registered with the C.N.C.M. on Jun. 25, 1990 under number 1-957. |
| 4695562 |
Synthetic peptide compounds |
September 22, 1987 |
| Peptide fragment of M protein of S. pyrogenes elecit opsonic antibodies which are type-specific for type 24 streptococci. |
| 4499080 |
Synthetic ST toxin, process for its preparation and its use as a vaccinating agent |
February 12, 1985 |
| The invention relates to novel synthetic peptides, process for their peparation and their application to the production of antibodies.These peptides include at the most 18 amino-acids and at the least 4 amino-acids in which n is equal to 1 or 2, and when n equals 1 the peptidic sequence |
